Pervasive developmental disorders. Childhood autism
Conditions
Interventions
Intervention 1: aripiperazole (2-15mg/day). Intervention 2: risperidone (0.5-3mg/day).
Treatment - Drugs
aripiperazole (2-15mg/day)
risperidone (0.5-3mg/day)
Sponsors
Vice chancellor for research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: DSM-IV diagnosis of autism spectrum disorders; both genders; being able to eat medication; providing written informed consent. Exclusion Criteria: unstable medical condition; evidence of active liver disease; unstable hypertension or cardiac disease; unstable asthma; and kidney disease as determined by the investigator; subjects who are allergic to the medications; initiation of new behavioral therapy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abbrant Behavior Checklis. Timepoint: every 4 week. Method of measurement: interview. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects. Timepoint: every 4 week. Method of measurement: interview. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed